Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VALIC Company I Health Sciences Fund (VCHSX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital growth. The fund normally invests at least 80% of its net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S.


1 month+1.65% 3 years+12.94%
3 months+2.96% 5 years+20.39%
1 year+24.92% Since inception+11.13%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+20.39%+16.80%
Expense ratio1.09%1.20%
Risk 5 year sharpe ratio1.221.09
Net assets$760.5M$226.1M
Average market cap$23.8B$30.9B
Average P/E25.526.2
Portfolio turnover30%30%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVALIC
Fund manager & tenureZiad Bakri / 1 Years
Minimal initial investment$0.00
Minimum IRA investment--


U.S. stock92.76%
International stock4.85%
Fixed income0.25%
Top 5 Sectors
Portfolio weighting
Healthcare 93.57%
Consumer service 1.09%
Industrial materials 0.89%
Financial service 0.35%
Hardware 0.19%
Top 10 Holdings
Portfolio weighting
UNH UnitedHealth5.72%
BDX Becton Dickinson and Co3.78%
ISRG Intuitive Surgical3.61%
VRTX Vertex Pharmaceuticals Inc3.17%
ALXN Alexion Pharmaceuticals Inc2.93%
CI Cigna Corp2.82%
AGN Allergan2.59%
HUM Humana Inc2.37%
A Agilent Technologies Inc2.12%
INCY Incyte Corp2.08%